CIK 0000906709 · Non-accelerated filer<br>Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943134940
- Phone
- 4154825300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $43,476
- in 2 filings
Net −$43,476. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-13 | Wilson Mark Andrew Chief Legal Officer | Grant or award | +165,938 | 385,294 | ||
| 2024-12-13 | Wilson Mark Andrew Chief Legal Officer | Grant or award · Stock Option | +331,875 | 331,875 | ||
| 2024-12-13 | Wilson Mark Andrew Chief Legal Officer | Grant or award · Stock Option | +325,000 | 325,000 | ||
| 2024-12-13 | ROBIN HOWARD W President & CEO | Grant or award | +410,625 | 1,242,705 | ||
| 2024-12-13 | ROBIN HOWARD W President & CEO | Grant or award · Stock Option | +821,250 | 821,250 | ||
| 2024-12-13 | ROBIN HOWARD W President & CEO | Grant or award · Stock Option | +1,300,000 | 1,300,000 | ||
| 2024-11-19 | Zalevsky Jonathan Chief R&D Officer | Sale | −7,785 | $1.01 | $8K | 243,019 |
| 2024-11-19 | Wilson Mark Andrew Chief Legal Officer | Sale | −6,407 | $1.01 | $6K | 218,856 |
| 2024-11-19 | ROBIN HOWARD W President & CEO | Sale | −16,278 | $1.01 | $16K | 832,080 |
| 2024-08-19 | Zalevsky Jonathan Chief R&D Officer | Sale | −6,866 | $1.28 | $9K | 250,804 |
| 2024-08-19 | Wilson Mark Andrew Chief Legal Officer | Sale | −5,651 | $1.28 | $7K | 225,263 |
| 2024-08-19 | ROBIN HOWARD W President & CEO | Sale | −14,881 | $1.28 | $19K | 848,358 |
| 2024-06-14 | CHESS ROBERT Director | Sale 10b5-1 | −19,500 | $1.20 | $23K | 255,273 |
| 2024-05-17 | ROBIN HOWARD W President & CEO | Sale | −16,650 | $1.75 | $29K | 863,239 |
| 2024-05-17 | Zalevsky Jonathan Chief R&D Officer | Sale | −7,355 | $1.75 | $13K | 257,670 |
| 2024-05-17 | Wilson Mark Andrew Chief Legal Officer | Sale | −6,260 | $1.75 | $11K | 230,414 |
| 2024-05-10 | Deep Track Capital, LP 10% owner | Sale | −56,000 | $1.78 | $100K | 18,344,000 |
| 2024-02-20 | Zalevsky Jonathan Chief R&D Officer | Sale | −9,014 | $0.68 | $6K | 265,025 |
| 2024-02-20 | Wilson Mark Andrew Chief Legal Officer | Sale | −7,606 | $0.68 | $5K | 236,674 |
| 2024-02-20 | ROBIN HOWARD W President & CEO | Sale | −20,033 | $0.68 | $14K | 879,889 |
Page 5 of 18 · 355 trades